Invention Grant
- Patent Title: Methods of treatment using a JAK inhibitor compound
-
Application No.: US15966438Application Date: 2018-04-30
-
Publication No.: US10406148B2Publication Date: 2019-09-10
- Inventor: Melanie A. Kleinschek , Glenn D. Crater
- Applicant: THERAVANCE BIOPHARMA R&D IP, LLC
- Applicant Address: US CA South San Francisco
- Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
- Current Assignee: THERAVANCE BIOPHARMA R&D IP, LLC
- Current Assignee Address: US CA South San Francisco
- Agent Jeffrey A. Hagenah; Florence Jovic
- Main IPC: A61K31/4545
- IPC: A61K31/4545 ; A61P27/02 ; A61K9/00 ; A61P11/00
Abstract:
The invention relates to methods of treating ocular diseases and certain respiratory diseases using the compound 5-ethyl-2-fluoro-4-(3-(5-(1-methylpiperidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-6-yl)phenol or a pharmaceutically-acceptable salt thereof.
Public/Granted literature
- US20180311226A1 METHODS OF TREATMENT USING A JAK INHIBITOR COMPOUND Public/Granted day:2018-11-01
Information query
IPC分类:
